155 related articles for article (PubMed ID: 18854345)
1. Factors affecting survival in juvenile systemic sclerosis.
Martini G; Vittadello F; Kasapçopur O; Magni Manzoni S; Corona F; Duarte-Salazar C; Nemcova D; Len CA; Garay SM; Ullman S; Zulian F;
Rheumatology (Oxford); 2009 Feb; 48(2):119-22. PubMed ID: 18854345
[TBL] [Abstract][Full Text] [Related]
2. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.
Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F;
Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611
[TBL] [Abstract][Full Text] [Related]
3. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
4. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
Steen VD; Medsger TA
Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
[TBL] [Abstract][Full Text] [Related]
5. Juvenile systemic sclerosis: a follow-up study of eight patients.
Szamosi S; Maródi L; Czirják L; Ellenes Z; Szücs G
Ann N Y Acad Sci; 2005 Jun; 1051():229-34. PubMed ID: 16126963
[TBL] [Abstract][Full Text] [Related]
6. Survival and causes of death in 366 Hungarian patients with systemic sclerosis.
Czirják L; Kumánovics G; Varjú C; Nagy Z; Pákozdi A; Szekanecz Z; Szucs G
Ann Rheum Dis; 2008 Jan; 67(1):59-63. PubMed ID: 17519276
[TBL] [Abstract][Full Text] [Related]
7. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis.
Ruangjutipopan S; Kasitanon N; Louthrenoo W; Sukitawut W; Wichainun R
J Med Assoc Thai; 2002 Nov; 85(11):1204-9. PubMed ID: 12546318
[TBL] [Abstract][Full Text] [Related]
8. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
[TBL] [Abstract][Full Text] [Related]
9. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
[TBL] [Abstract][Full Text] [Related]
10. Predictive markers for development of severe organ involvement in patients with systemic sclerosis.
Ysebrant de Lendonck L; Ocmant A; Roufosse F; Cogan E
Ann N Y Acad Sci; 2005 Jun; 1051():455-64. PubMed ID: 16126987
[TBL] [Abstract][Full Text] [Related]
11. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres.
Fransen J; Popa-Diaconu D; Hesselstrand R; Carreira P; Valentini G; Beretta L; Airo P; Inanc M; Ullman S; Balbir-Gurman A; Sierakowski S; Allanore Y; Czirjak L; Riccieri V; Giacomelli R; Gabrielli A; Riemekasten G; Matucci-Cerinic M; Farge D; Hunzelmann N; Van den Hoogen FH; Vonk MC
Ann Rheum Dis; 2011 Oct; 70(10):1788-92. PubMed ID: 21784727
[TBL] [Abstract][Full Text] [Related]
12. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
[TBL] [Abstract][Full Text] [Related]
13. [Causes of death of patients with systemic sclerosis].
Chwieśko S; Sierakowski S; Kowal-Bielecka O
Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
[TBL] [Abstract][Full Text] [Related]
14. A descriptive and prognostic study of systemic sclerosis-associated myopathies.
Ranque B; Authier FJ; Le-Guern V; Pagnoux C; Berezne A; Allanore Y; Launay D; Hachulla E; Kahan A; Cabane J; Gherardi R; Guillevin L; Mouthon L
Ann Rheum Dis; 2009 Sep; 68(9):1474-7. PubMed ID: 19054827
[TBL] [Abstract][Full Text] [Related]
15. Geoepidemiology of systemic sclerosis.
Ranque B; Mouthon L
Autoimmun Rev; 2010 Mar; 9(5):A311-8. PubMed ID: 19906362
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
[TBL] [Abstract][Full Text] [Related]
17. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
Shand L; Lunt M; Nihtyanova S; Hoseini M; Silman A; Black CM; Denton CP
Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
[TBL] [Abstract][Full Text] [Related]
18. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
19. Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database.
Foeldvari I; Tyndall A; Zulian F; Müller-Ladner U; Czirjak L; Denton C; Kowal-Bielecka O; Bancel DF; Matucci-Cerinic M
Rheumatology (Oxford); 2012 Oct; 51(10):1832-7. PubMed ID: 22728264
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis in childhood.
Foeldvari I
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii28-9. PubMed ID: 16987828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]